SciELO - Scientific Electronic Library Online

vol.49 issue4Rectocele and anal sphincter defect - surgical anatomy and combined repairIntestinal inflammatory myofibroblastic tumour author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • On index processSimilars in Google


South African Journal of Surgery

On-line version ISSN 2078-5151
Print version ISSN 0038-2361

S. Afr. j. surg. vol.49 n.4 Cape Town Nov. 2011




Long-term outcomes after laparoscopic total mesorectal excision for advanced rectal cancer



L. LiuI; J. GongI; Y. CaoII; L. ZhangII; G. ZhangIII; P. WangIV

IM.M.; Department of General Surgery, General Hospital of Chengdu Military Region, Chengdu, People's Republic of China
IIM.D.; Department of General Surgery, General Hospital of Chengdu Military Region, Chengdu, People's Republic of China
IIIB.M.; Department of General Surgery, General Hospital of Chengdu Military Region, Chengdu, People's Republic of China
IVB.M. ; Department of General Surgery, General Hospital of Chengdu Military Region, Chengdu, People's Republic of China




PURPOSE: The aim of this study was to evaluate the long-term outcomes of laparoscopic total mesorectal excision in the treatment of advanced rectal cancer in a randomised population.
METHODS: Between 2001 and 2005, 125 patients (70 males, 55 females, mean age 55.5 (standard deviation (SD) 11) years, range 25 - 81 years) with rectal cancer were evaluated and prospectively followed up in our hospital (mean follow-up 42 (SD 23 months, range 5 - 113 months). The 5-year overall survival rate, 5-year disease-free survival rate and recurrence rate were analysed.
RESULTS: There were 54 cases of cancer defined as UICC stage II and 68 cases defined as stage III. Of these cases, 22 were localised to the upper rectum, 50 to the middle rectum and 53 to the lower rectum. The 5-year overall survival rates were 71.3% and 51% among the stage II and the stage III patients, respectively. The 5-year disease-free survival rates were 59.2% and 45.4% among the stage II and the stage III cancer patients, respectively. The overall recurrence rate was 16.8% (local recurrence rate 11.25%, distant recurrence rate 8%). Multivariate analysis showed that age and size were independent predictors of overall survival (p=0.006 and p<0.001 for stage II and stage III patients, respectively).
CONCLUSIONS: Our results suggest good long-term outcomes of laparoscopic surgery in the treatment of rectal cancer. However, this technique should be used with caution in older patients and patients with larger tumours.



“Full text available only in PDF format”



1. Fukunaga Y, Higashino M, Tanimura S, et al. Laparoscopic rectal surgery for middle and lower rectal cancer. Surg Endosc 2010;4:145-151.         [ Links ]

2. Denoya P, Wang H, Sands D, et al. Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surg Endosc 2010;24:933-938.         [ Links ]

3. Poon JT, Law WL. Laparoscopic resection for rectal cancer: a review. Ann Surg Oncol 2009;16:3038-3047.         [ Links ]

4. Krones CJ, Stumpf M, Schumpelick V. Surgery for rectal cancer. Chirurg 2009;80:303-310.         [ Links ]

5. Lange MM, Rutten HJ, van de Velde CJ. One hundred years of curative surgery for rectal cancer: 1908-2008. Eur J Surg Oncol 2009;35:456-463.         [ Links ]

6. Row D, Weiser MR. An update on laparoscopic resection for rectal cancer Cancer Control 2010;17:16-24.         [ Links ]

7. Lelong B, Bege T, Esterni B, et al. Short-term outcome after laparoscopic or open restorative mesorectal excision for rectal cancer: a comparative cohort study. Dis Colon Rectum 2007;50:176-183.         [ Links ]

8. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637-645.         [ Links ]

9. Staudacher C, Di Palo S, Tamburini A, et al. Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases. Surg Oncol 2007;suppl 1:s113-116.         [ Links ]

10. Barlehner E, Benhidjeb T, Anders S, et al. Laparoscopic resection for rectal cancer: outcomes in 194 patients and review of the literature. Surg Endosc 2005;19:757-766.         [ Links ]

11. Pricolo VE, Abodeely A, Resnick M. Distal margins in radical resections for rectal cancer after chemoradiation therapy: How short is long enough? Dig Surg 2010;27:185-189.         [ Links ]

12. Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998;133:894-899.         [ Links ]

13. Lezoche E, Guerrieri M, Sanctis AD, et al. Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years. Surg Endoc 2006;20:546-553.         [ Links ]

14. Yu J, Zhang C, Wang YN, et al. Laparoscopic versus open total mesorectal excision for the middle-lower rectal cancer: a clinical comparative study. Zhonghua Wei Chang Wai Ke Za Zhi 2009;12:573-576.         [ Links ]

15. Ding KF, Chen R, Zhang JL, et al. Laparoscopic surgery for the curative treatment of rectal cancer: results of a Chinese three-center case-control study. Surg Endoc 2009;23:845-861.         [ Links ]

16. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemo- radiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.         [ Links ]

17. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03. J Clin Oncol 2009;27:5124-5130.         [ Links ]

18. Glynne-Jones R, Grainger J, Harrison M, et al. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 2006;94:363-371.         [ Links ]

19. Ferenschild FT, Dawson I, de Wilt JH, et al. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis 2009;24:923-929.         [ Links ]

20. Genovesi D, Cefaro GA, Vinciguerra A, et al. Retrospective long-term results and prognostic factors of postoperative treatment for UICC stage II and III rectal cancer. Tumori 2009;95:675-682.         [ Links ]

21. Andreoni B, Chiappa A, Bertani E, et al. Surgical outcomes for colon and rectal cancer over decade: results from a consecutive monocentric experience in 902 unselected patients. World J Surg Oncol 2007;5:73.         [ Links ]

22. Peparini N, Maturo A, Di Matteo FM, et al. Long-term survival and recurrences after total nerve-sparing surgery for rectal cancer. Hepatogastroenterology 2006;53:850-853.         [ Links ]

23. Leroy J, Jamali F, Forbes L, et al. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery. Surg Endosc 2004;18:281-289.         [ Links ]

24. Lam HD, Stefano M, Tran-Ba T, Tinton N, Cambier E, Navez B. Laparoscopic versus open techniques in rectal cancer surgery: a retrospective analysis of 121 sphincter-saving procedures in a single institution. Surg Endosc 2011;25:454-462.         [ Links ]

25. Kim YW, Kim NK, Min BS, et al. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 2009;249:965-972.         [ Links ]

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License